SCHEDULE 13G

Statement of Beneficial Ownership

Celldex Therapeutics, Inc. Filed 2026-08-14 Acc 0000080255-26-000537

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-08-14 SCHEDULE 13G Statement of Beneficial Ownership
2026-05-12 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)